Synta Pharmaceuticals – Ganetespib, a non-ansamycin inhibitor of Hsp90, enhances the activity of the microtubule targeting docetaxel, paclitaxel, and vincristine in multiple non-small cell lung cancer xenograft models according to an article published in the journal Investigational New Drugs.